Congenital Pseudarthrosis
Congenital pseudarthrosis is a rare condition where a bone, often the tibia, fails to heal properly after a fracture or does not form correctly, leading to instability and potential deformity.
Congenital Pseudarthrosis of the Tibia: NVD003 Treatment Study
We are evaluating how effective and safe NVD003 is for children undergoing surgery for congenital pseudarthrosis of the tibia. The study will also look at its impact on bone healing and quality of life.
>2 years6-10 visitsConfirmation phase (III)Post-Trial Drug AccessNo PlaceboCost ReimbursementInvestigational MedicinesOrthopedics and TraumatologyPediatrics
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 17 years old or younger?
- Do you have a diagnosis of CPT (a type of bone condition)?
- Are you currently pregnant or breastfeeding?
- Are you taking any medications that affect bone health, like steroids or bisphosphonates?
- Have you had any major infections or significant health issues recently?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Nvd003
Autologous Adipose-Derived Stem Cells
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Cliniques Universitaires Saint-Luc
Orthopedics and Musculoskeletal Traumatology
Sint-Stevens-Woluwe, Belgium
Centre Hospitalier Universitaire Amiens Picardie
Service de chirurgie Orthopédie et Traumatologie pédiatrique
Colomiers, France
Hopital Necker Enfants Malades
Chirurgie orthopédique et traumatologie pédiatrique
Montrouge, France
Sponsor: Novadip Biosciences
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.